Statistics on Biotechnology Use Results by sector of operation Company sector. Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production Unidades: specified in variables Total Main Secondary dwellings Tool Companies that carry out R&D in Biotechnology 1.078 526 173 379 %Companies according to biotechnology used: Genetic code 35 45 22 27 %Companies according to biotechnology used: Functional units 42 52 37 30 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 27 34 22 19 %Companies according to biotechnology used: Bioprocesses 49 43 51 56 %Companies according to biotechnology used: Sub-cellular organisms 8 12 6 4 %Companies according to biotechnology used: Bio-computing 22 33 17 9 %Companies according to biotechnology used: Nanobiotechnology 14 19 15 6 %Companies according to biotechnology used: Other 12 13 14 10 %Company by field(s) of ultimate application of biotechnology use: Human Health 48 68 39 25 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 20 21 20 19 %Company by field(s) of ultimate application of biotechnology use: Food products 33 26 30 44 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 24 22 28 25 %Company by field(s) of ultimate application of biotechnology use: Environment 15 12 26 14 %Company by field(s) of ultimate application of biotechnology use: Industry 14 14 20 9 Personnel in R&D in biotechnology (no. of persons) 10.191 5.753 1.481 2.956 Personnel in R&D in biotechnology (no. of persons): Researchers 5.774 3.440 849 1.485 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 4.417 2.314 632 1.471 Personnel in R&D in biotechnology (no. of persons): women 5.525 3.332 769 1.424 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 3.015 1.902 419 694 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 2.511 1.431 350 730 Personnel in R&D in biotechnology (FTE) 7.191,4 4.611,5 889,5 1.690,4 Personnel in R&D in biotechnology (FTE): Researchers 4.276,6 2.783,2 566 927,5 Personnel in R&D in biotechnology (FTE): Technicians and assistants 2.914,7 1.828,3 323,5 763 Personnel in R&D in biotechnology (FTE): women 3.985,4 2.631,7 473,6 880,2 Personnel in R&D in biotechnology (FTE): (women) Researchers 2.234 1.505,4 276,8 451,8 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.751,4 1.126,3 196,7 428,4 Internal expenditure on R&D (thousands of euros) 578.171 392.202 77.155 108.814 1) By nature of the expense: Current expenses 517.601 345.782 70.758 101.061 1.1) Remuneration to researchers 213.755 144.473 30.720 38.563 1.2) Remuneration to technicians and assistants 98.440 61.637 11.993 24.810 1.3) Other current expenses 205.406 139.672 28.045 37.689 2) By nature of the expense: Capital expenses 60.570 46.420 6.397 7.753 2.1) Land and buildings 22.609 21.900 79 630 2.2) Equipment and instruments 36.169 23.279 6.254 6.636 2.3) Acquisition of specific R+D software 1.793 1.242 63 488 1) By origin of the funds: National funds 487.615 312.995 69.889 104.731 1.1) Own funds 330.459 205.081 45.123 80.255 1.2) From companies 45.462 23.837 13.797 7.827 1.3) Public Administration funds 66.189 40.409 10.721 15.060 1.4) From Universities 25.148 25.101 32 15 1.5) From non profit private institutions 20.357 18.567 216 1.575 1) By origin of the funds: Foreign funds 90.556 79.207 7.266 4.083 2.1) From EU programmes 20.932 15.392 3.369 2.172 2.2) Other foreign funds 69.624 63.816 3.897 1.911 Purchase of R&D services in biotechnology (thousands of euros) 166.022 131.839 27.652 6.530 Purchase of R&D services in biotechnology (thousands of euros): In Spain 97.455 77.835 14.188 5.432 Purchase of R&D services in biotechnology (thousands of euros): Abroad 68.567 54.005 13.464 1.098 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 46 56 45 33 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 13 12 17 13 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 14 14 19 12 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 14 14 22 10 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets 17 20 23 12 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels 17 20 21 11 %Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception 18 18 23 17 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 35 39 41 28 %Companies that consider the following obstacles as very important considering biotechnology development : Time / cost 49 54 49 41 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 21 21 21 21 % Companies that have requested biotechnology patents 15 24 10 7 Number of patents requested 526 397 72 57 % Companies with income of an international origin related to biotechnological activities 26 35,9 12,8 18,2 % Turnover representing income of an international origin related to biotechnological activities 1,4 11,7 . 0,9 % Income of of an international origin related to biotechnological activities distributed in: Income received from the EU 63,8 66,2 73 49,7 % Income of of an international origin related to biotechnological activities distributed in: Income received from other countries 36,2 33,8 27,1 50,3 % Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services 91,6 91,3 64,7 95,1 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 0,9 0,6 . 3,1 % Income of an international origin related with activities according to the classification: Operating source abroad 1,9 1,6 34,9 1,4 % Income of an international origin related with activities according to the classification: Other 5,6 6,6 0,4 0,5 Notas: . '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute